Interventional cardiology is the branch of cardiology which was develop by Andreas Gruentzig. This technique involves the use of catheter and stents for the treatment of heart diseases. According to World Health Organization (WHO), Asia Pacific has the largest number of populations suffering from cardiovascular diseases owing to huge diabetic and obese population. The major driving factors for the growth of the market are increasing prevalence diabetes, heart attack and obesity. Changing lifestyle, lack of exercise and rapid development in medical devices had also contributed in growth of the market. Whereas on other hand, high cost of manufacturing devices and strict regulatory rules for development of catheter and stents had hamper the growth of the market. Asia Pacific interventional cardiology market is expected to grow at a CAGR of 8 % during forecasted period 2022-2030